Displaying 1 - 1 of 1
| Active Ingredient | MILRINONE LACTATE |
| Therapeutic Class | CARDIOTONIC AGENTS |
| Indications | Short-term treatment of severe congestive heart failure unresponsive to conventional maintenance therapy; acute heart failure after cardiac surgery . |
| Caution | Monitor renal function. Ectopic beats, ventricular tachycardia, supraventricular arrhythmias, hypotension, headache. |
| Dose Range | Intravenous injection over 10 minutes, either undiluted or diluted before use, 50 micrograms/kg followed by intravenous infusion at a rate of 375-75 nanograms/kg/minute, usually for up to 12 hours following surgery or for 48-72 hours in congesti |
| Drug Interactions | |
| Pregnancy | Manufacturer advises use only if potential benefit outweighs risk. |
| Breast Feeding | Use milrinone with caution in lactating women. |